Skip to main content

Table 3 Factors associated with loss of follow-up in the first 3 years after surgery (N = 420)

From: Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China

Characteristic

Unadjusted OR (95% CI)

Adjusted OR (95% CI) *

Age(years)

  < 65

1.0

1.0

  > 65

5.70 (3.28–9.92)

2.31 (1.13–4.73)

Medical insurance coverage

 High (> 70%)

1.0

1.0

 Medium (50–70%)

2.36 (1.28–4.36)

3.21 (1.53–6.73)

 Low (< 50%)

2.86 (1.44–5.66)

3.58 (1.57–8.15)

Family history

 Negative

1.0

 

 Positive

1.24 (0.47–3.24)

 

Marital status

 Married

1.0

 

 Unmarried

2.20 (0.93–5.19)

 

Employment status

 Employed

1.0

 

 Unemployed

1.15 (0.58–2.28)

 

 Retired

0.77 (0.42–1.41)

 

Tumor size (cm)

 0–1.9

1.0

 

 2–4.9

1.28 (0.79–2.09)

 

  > 5

2.44 (0.89–6.68)

 

Positive axillary nodal status

 0

1.0

 

 1–3

1.15 (0.68–1.94)

 

 4–9

1.74 (0.82–3.69)

 

  > 10

1.47 (0.55–3.96)

 

TNM stage

 Stage 0-I

1.0

 

 Stage II

1.17 (0.70–1.95)

 

 Stage III

1.44 (0.73–2.83)

 

Histological subtype

 In Situ

1.0

 

 Ductal/Lobular/Mixed/Metaplastic

0.49 (0.11–2.08)

 

 Tubular/Mucinous/Papillary

0.13 (0.01–1.54)

 

ER

 Negative

1.0

 

 Positive

1.32 (0.79–2.20)

 

PR

 Negative

1.0

 

 Positive

1.24 (0.76–2.01)

 

HER2

 Negative

1.0

 

 Positive

0.84 (0.47–1.52)

 

Surgery of breast

 Lumpectomy

1.0

 

 Mastectomy

1.37 (0.86–2.18)

 

Axillary surgery

 Sentinel lymph node biopsy

1.0

1.0

 Axillary lymph node dissection

1.57 (0.97–2.53)

2.51 (1.39–4.52)

Chemotherapy

 Yes

1.0

1.0

 No

5.27 (3.19–8.70)

3.48 (1.84–6.57)

Radiotherapy

 Yes

1.0

1.0

 No

5.32 (3.25–8.71)

3.90 (2.14–7.10)

Targeted therapy

 Yes

1.0

 

 No

3.24 (1.13–9.28)

 

Endocrine therapy

 Yes

1.0

 

 No

1.65 (1.03–2.64)

 
  1. Abbreviations: ER Estrogen receptor status, PR Progesterone receptor status, HER 2 Human epidermal growth factor receptor 2
  2. *Adjusted ORs in the final model from step-wise logistic regression analysis by including all the variables in the Table with P < 0.10 from univariate logistic regression and eliminate each at a time justified by likelihood ratio test [13]